{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:55:14Z","timestamp":1789991714145,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/beog.2001.0270","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"193-203","source":"Crossref","is-referenced-by-count":21,"title":["Male contraception"],"prefix":"10.1053","volume":"16","author":[{"given":"Christina","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S","family":"Swerdloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beog.2001.0270_RF1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2307\/1966856","article-title":"Contraceptive failure in the United States: A critical review of literature","volume":"18","author":"Trussel","year":"1987","journal-title":"Studies in Family Planning"},{"key":"10.1053\/beog.2001.0270_RF2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-5347(17)38334-9","article-title":"The no-scalpel vasectomy","volume":"145","author":"Li","year":"1991","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.2001.0270_RF3","first-page":"193","article-title":"Percutaneous injection of vas deferens","volume":"1","author":"Li","year":"1980","journal-title":"Chinese Journal of Urology"},{"key":"10.1053\/beog.2001.0270_RF4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2605.1992.tb01140.x","article-title":"Safety and efficacy of percutaneous injection of polyurethane elastomer (MPU) plugs for vas occlusion in man","volume":"15","author":"Chen","year":"1992","journal-title":"International Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF5","series-title":"Hormonal control of male fertility","author":"Patanelli","year":"1978"},{"key":"10.1053\/beog.2001.0270_RF6","series-title":"Hormonal Control of Male Fertility","first-page":"71","article-title":"Clinical evaluation of testosterone enanthate for induction and maintenance of reversible azoospermia in man","author":"Cunningham","year":"1978"},{"key":"10.1053\/beog.2001.0270_RF7","series-title":"Hormonal control of male fertility","first-page":"41","article-title":"Clinical evaluation of testosterone enanthate in the reversible suppression of spermatogenesis in the human male: efficacy, mechanism of action, and adverse effects","author":"Swerdloff","year":"1978"},{"key":"10.1053\/beog.2001.0270_RF8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/beog.2001.0270_RF9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","volume":"65","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1053\/beog.2001.0270_RF10","first-page":"1326","article-title":"Suppression of human spermatogenesis by testosterone implants in man","volume":"75","author":"Handelsman","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF11","first-page":"2394","article-title":"Potential of testosterone buciclate for male contraception: endocrine differences between responders and non-responders","volume":"80","author":"Behre","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/j.1939-4640.1998.tb02086.x","article-title":"A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men","volume":"19","author":"Zhang","year":"1998","journal-title":"Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1530\/eje.0.1400414","article-title":"Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies","volume":"140","author":"Behre","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1053\/beog.2001.0270_RF14","first-page":"3642","article-title":"A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men","volume":"84","author":"Zhang","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2265.2000.01097.x","article-title":"Intramuscular testosterone undecanoate with or without oral levornogestrel: a randomized placebo controlled clinical trial for male contraception","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1053\/beog.2001.0270_RF16","series-title":"Male Reproductive Function","first-page":"303","article-title":"Male contraception in the 21st century","author":"Wang","year":"1999"},{"key":"10.1053\/beog.2001.0270_RF17","series-title":"Male Reproductive Function","first-page":"157","article-title":"Androgen replacement therapy, risks and benefits","author":"Wang","year":"1999"},{"key":"10.1053\/beog.2001.0270_RF18","series-title":"Male Reproductive Function","first-page":"173","article-title":"The safety androgens: prostate and cardiovascular disease","author":"Handelsman","year":"1999"},{"key":"10.1053\/beog.2001.0270_RF19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2605.1978.tb00517.x","article-title":"Hormonal contraception for men","volume":"Suppl 2","author":"Schearer","year":"1978","journal-title":"International Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF20","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotrophin levels with fewer metabolic effects than higher dosage combinations","volume":"20","author":"Anawalt","year":"1999","journal-title":"Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0015-0282(16)56411-5","volume":"60","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1053\/beog.2001.0270_RF23","first-page":"112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism","volume":"84","author":"Wu","year":"1999","journal-title":"Journal of Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF24","first-page":"704","article-title":"Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high density lipo protein suppression","volume":"14","author":"Anawalt","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1053\/beog.2001.0270_RF25","first-page":"3018","article-title":"A combined regimen of cyproterone acetate and testosterone enanthate as a potentially high effective male contraceptive","volume":"81","author":"Meriggiola","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/13.5.1225","article-title":"Low dose of cyproterone acetate and testosterone enanthate for contraception in men","volume":"13","author":"Meriggiola","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1053\/beog.2001.0270_RF27","first-page":"303","article-title":"Intramuscular testosterone undecanoate and nonethisterone enanthate in a clinical trial for male contraception","volume":"86","author":"Kamischke","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF28","first-page":"4113","article-title":"Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot","volume":"81","author":"Handelsman","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF29","first-page":"1244","article-title":"Clinical trial of transdermal testosterone and oral levonogestrel for male contraception","volume":"84","author":"B\u00fcchter","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0010-7824(80)90005-0","article-title":"Use of low-dosage cyprosterone acetate as a male contraceptive","volume":"21","author":"Wang","year":"1980","journal-title":"Contraception"},{"key":"10.1053\/beog.2001.0270_RF31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/jm970699s","article-title":"Syntheses and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono [5,6-g] quinolines","volume":"41","author":"Hamann","year":"1998","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1053\/beog.2001.0270_RF32","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1210\/endo.130.6.1597164","article-title":"The biological activity of 7 \u03b1-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone","volume":"130","author":"Kumar","year":"1992","journal-title":"Endocrinology"},{"key":"10.1053\/beog.2001.0270_RF33","first-page":"3556","article-title":"7\u03b1-Methyl-19-northestosterone maintains sexual behavior and mood in hypogonadal men","volume":"84","author":"Anderson","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem-60-5-998","article-title":"Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist and androgen","volume":"60","author":"Bhasin","year":"1985","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1984.tb00066.x","article-title":"Hormonal effects of GnRH agonist in the human male: II. Testosterone enhances gonadotrophin suppression induced by GnRH agonist","volume":"20","author":"Bhasin","year":"1984","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beog.2001.0270_RF36","first-page":"84","article-title":"Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception","volume":"74","author":"Behre","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/jcem-64-5-931","article-title":"Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men","volume":"64","author":"Pavlou","year":"1987","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF38","first-page":"476","article-title":"Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate","volume":"75","author":"Tom","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF39","first-page":"427","article-title":"Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens","volume":"77","author":"Bagatell","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF40","first-page":"393","article-title":"Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men","volume":"75","author":"Behre","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF41","first-page":"3527","article-title":"Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate is maintained by testosterone enanthate alone","volume":"83","author":"Swerdloff","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF42","series-title":"Hormonal Control of Male Fertility","first-page":"173","article-title":"Effects of testosterone and estradiol, silastic implants, on spermatogenesis in rats and monkeys","author":"Ewing","year":"1978"},{"key":"10.1053\/beog.2001.0270_RF43","first-page":"902","article-title":"Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I. Higher 5\u03b1 reductase activity in oligozoospermic men administered supraphysiological doses of testosterone","volume":"81","author":"Anderson","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF44","first-page":"870","article-title":"Graded testosterone infusions distinguish gonadotropin negative feedback responsiveness in Asian and White men\u2014A clinical research center study","volume":"83","author":"Wang","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF45","first-page":"2104","article-title":"Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects","volume":"83","author":"Santner","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/j.1939-4640.1998.tb02015.x","article-title":"Ethnic difference in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives","volume":"19","author":"Johnson","year":"1998","journal-title":"Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem.83.1.4485","article-title":"Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptability of germ cells to programmed cell death","volume":"83","author":"Sinha-Hikim","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beog.2001.0270_RF48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2605.1998.00092.x","article-title":"Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug","volume":"21","author":"Waites","year":"1998","journal-title":"International Journal of Andrology"},{"key":"10.1053\/beog.2001.0270_RF49","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humrep\/15.3.672","article-title":"Oestradiol enhances testosterone-induced suppression of human spermatogenesis","volume":"15","author":"Handelsman","year":"2000","journal-title":"Human Reproduction"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693401902706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693401902706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:16:56Z","timestamp":1704320216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693401902706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1521693401902706"],"URL":"https:\/\/doi.org\/10.1053\/beog.2001.0270","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}